Clinical observation of FOLFOX4 protocol for advanced colorectal cancer
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:FOLFOX4方案治疗晚期结直肠癌的临床观察
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Dongping WU
			        		
			        		;
		        		
		        		
		        		
			        		Jieqing LU
			        		
			        		;
		        		
		        		
		        		
			        		Feng TAO
			        		
			        		;
		        		
		        		
		        		
			        		Jianfang WANG
			        		
			        		;
		        		
		        		
		        		
			        		Songxiang WANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		FOLFOX4;
			        		
			        		
			        		
				        		Oxaliplatin;
			        		
			        		
			        		
				        		LV;
			        		
			        		
			        		
				        		5-Fu bolus;
			        		
			        		
			        		
				        		Colorectal cancer
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Cancer Research and Clinic
	            		
	            		 2001;0(04):-
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To evaluate the efficacy and toxicity of the protocol of FOLFOX4 for advanced colorectal cancer. Methods 27 patients received FOLFOX4oxaliplatin 85 mg/m2 as a 2-hour infusion on day 1 and a 2-hour infusion of LV (200 mg?m-2?d-1) followed by a 5-Fu bolus (400 mg?m-2?d-1) and 22-hour infusion (600 mg?m-2?d-1) for 2 consecutive days every 2 weeks. Four courses were carried out with an interval of one month. Results The total effective rate was 44.44 %, CR(3.70 %), PR(40.74 %). Median survival of all patients was 10.0 months. Mean Survival was 11.5 months. One year survival rate was 30.02 %. Median duration of 12 effective patients were 5.3 months. Median survival of effective patients and non-effective was 11.8 and 8.5 months respectively(P